IHI/NPSF Project Seeks to Improve the Assessment and Management of Acute Pain

The goal of this project is to provide safety and clinical leaders with guidelines about the best processes to safely manage acute pain.

The Institute for Healthcare Improvement (IHI), which merged with the National Patient Safety Foundation (NPSF) in May, has received support from Pacira Pharmaceuticals, Inc., to develop a tool to help reduce harm to patients from the over administering of opioids to treat acute pain. The tool will specifically address patients being treated in inpatient and emergency department settings.

“Pain management and related opioid safety issues have become a critical threat to public health. While a number of public and private agencies are committed to advancing safe opioid management practices and have developed resources accordingly, much of this work has focused on the management of chronic pain,” said Tejal K. Gandhi, MD, MPH, CPPS, Chief Clinical and Safety Officer, IHI. “The goal of this project is to provide safety and clinical leaders with guidelines about the best processes to safely manage acute pain.”

As part of the project, IHI/NPSF will convene a group of experts across disciplines, including patient safety, clinical leadership, orthopedics, anesthesiology, medication safety, and hospital pharmacy, among others, to develop an acute pain safety assessment and intervention tool to help health professionals more safely prescribe and manage opioids. System design and process issues will be addressed, as well as IT system alerts, metrics, and various other elements of safe opioid management.

The problems associated with opioids to control acute pain are multifaceted. For example, one study found that, with some common surgical procedures, patients given opioids for the first time in the postsurgical period are at increased risk of chronic opioid overuse. Recent research also found that opioid-related adverse drug events occur in 11 percent of patients, with those over 65 years of age or with certain chronic conditions or prior opioid use being at greatest risk.

“The connection between postsurgical opioid prescribing and the potential for adverse events, including long-term use, addiction, and dependence, is clear,” said Dave Stack, CEO and Chairman of Pacira. “Pacira is…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *